The cost-effectiveness of the nicotine transdermal patch for smoking cessation

Preventive Medicine

Volumn 26, Issue 2, 1997, Pages 264-270

  Wasley, Mark A ^a   McNagny, Sally E ^a   Phillips, V L ^b   Ahluwalia, Jasjit S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

cost benefit analysis; nicotine; smoking cessation

Indexed keywords

NICOTINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031105457     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1996.0127     Document Type: Article

References (34)

1. MMWR. 41:1994;428-429.
2. MMWR. 40:1991;62-71.
3. Department of Health and Human Services, 1988, The health consequences of smoking: nicotine addiction. A report of the Surgeon General, Public Health Service, Gov. Printing Office, Washington.
4. Fiore M C, Novotny T E, Pierce J P, Giovino G A, Hatiandreu E J, Newcomb P A. Methods used to quit smoking in the United States: do cessation programs help. JAMA. 263:1990;2760-2765.
5. Cepeda-Benito A. A meta-analysis review of the efficacy of nicotine chewing gum. J Consult Clin Psychol. 61:1993;822-830.
6. Fisher E B, Haire-Joshu D, Morgan G D. Smoking and smoking cessation. Am Rev Respir Dis. 142:1990;702-720.
7. Oster G, Huse D M, Delea T E, Colditz G A. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA. 256:1986;1315-1318.
8. Fiore M C, Smith S S, Jorenby D E, Baker T B. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA. 271:1994;1940-1947.
9. Cummings S R, Rubin S M, Oster G. The cost-effectiveness of counseling smoker to quit. JAMA. 261:1989;75-79.
10. Daughton D M, Heatley S A, Prendergast J J. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy: a randomized, placebo-controlled, double-blind study. Arch Intern Med. 151:1991;749-752.
11. Russel M AH, Stapleton J A, Feyerabend C. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ. 206:1993;1308-1312.
12. Evans D, Lane D S. Long-term outcome of smoking cessation workshops. Am J Public Health. 70:1980;725-727.
13. Hunt W A, Bespalec D A. An evaluation of current methods of modifying smoking behavior. J Clin Psychol. 30:1973;431-438.
14. Tonnesen P, Norregaard J, Sawe U. Two-year outcome in smoking cessation trial with a nicotine patch. J Smoking Relat Dis. 3:1992;241-245.
15. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA. 275:1996;1247-1251.
16. Pierce J P, Fiore M C, Novotny T E, Hatziandreu E J, Davis R M. Trends in cigarette smoking in the United States: projections to the year 2000. JAMA. 261:1989;61-65.
17. Tsevat J. Impact and cost-effectiveness of smoking interventions. Am J Med. 93:1992;43S-47S.
18. Grover S A, Gray-Donald K, Joseph L, Abrahamowicz M, Coupal L. Life expectancy following dietary modification or smoking cessation. Arch Intern Med. 154:1994;1697-1704.
19. Cummings S R, Rubin S M, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA. 261:1989;75-79.
20. Plans P, Navas E, Tarin A, Rodriguez N, Gali N, Gayta J L. Coste-efectividad de los metodos de cesacion tabaquica (Cost-effectiveness of smoking cessation methods). Med Clin (Barcelona). 104:1995;49-54.
21. 1995, Public Health Service contract pricing (published by individual pharmaceutical companies). Overseen by the Department of Health and Human Services, 4th quarter.
22. Gourlay S. The pros and cons of transdermal nicotine therapy. Med J Australia. 160:1994;152-159.
23. Jamrozik K, Fowler G, Vessey M. Placebo controlled trial of nicotine chewing gum in general practice. BMJ. 289:1984;794-797.
24. Russel M A, Merriman R, Stapleton J. Effect of nicotine chewing gum as an adjunct in general practitioners' advice against smoking. BMJ. 287:1983;1782-1785.
25. Orleans C T, Resch N, Noll E. Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at 'real-world' patch users. JAMA. 271:1994;601-607.
26. Department of Health and Human ServicesHealth Care Financing Administration, Rules and regulations, 63595.
27. Health Care Financing Administration, Rules and regulations, 59793.
28. Health Care Financing Administration, Physicians' Medicare fee schedule: 1995 fee schedule.
29. Krumholz H M, Cohen B J, Tsevat J, Pasternak R C, Weinstein M C. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol. 22:1993;1697-1702.
30. Schauffler H H, Parkinson M D. Health insurance coverage for smoking cessation services. Health Educ. 20:1993;185-206.
31. Drummond M F, Stoddart G L, Torrance G W. Methods for the economic evaluation of health care programmes. 1988;Oxford Univ. Press, Oxford.
32. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease. Part II. Preventive therapies. Prog Cardiovasc Dis. 37:1995;243-271.
33. Hughes J R, Wadland W C, Fenwick J W. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med. 20:1991;486-496.
34. Wagner E H, Curry S J, Grothaus L, Saunders K W, McBride C M. The impact of smoking and quitting on health care use. Arch Intern Med. 155:1995;1789-1795.